A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)
A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)
Active, not recruiting · NCT02724228 · Registry updated 2026-03-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH) | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, achondroplasia, bone disorder, endocrine system disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasia | Active, not recruiting | Phase 2 | 2026-03-13 | NCT02724228 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BioMarin Pharmaceutical | 32 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ann and Robert H. Lurie Childrens Hospital of Chicago | Chicago | United States | 4 |
| Baylor College of Medicine | Houston | United States | 306 |
| Children's Hospital & Research Center Oakland | Oakland | United States | 4 |
| Guys & St. Thomas NHS Foundation Trust Evelina Hospital | London | United Kingdom | 1 |
| Harbor - UCLA Medical Center | Torrance | United States | 3 |
| Institut Necker | Paris | France | 1 |
| Johns Hopkins McKusick - Institute of Genetic Medicine | Baltimore | United States | 1 |
| Murdoch Children's Research Institute | Parkville | Australia | 21 |
| Vanderbilt University | Nashville | United States | 1 |